- Home
- » Tags
- » Cantuzumab ravtansine
Top View
- Safety of Medicines
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
- Prescrire Contribution to Proposed INN List
- IMSN Open Letter on Antibody-Drug Conjugate 2151012
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Gm, Ke, Lr, Ls, Mw, Mz, Na, Rw, Sd, Sl, St, Sz, Tz, Ug, Zm, Zw
- Anti-Alphavbeta3 Monoclonal Antibody EMD 525797 (CUI C2830088) Add to Cart
- QSAR Model Development for Early Stage Screening of Monoclonal Antibody Therapeutics to Facilitate Rapid Developability
- (INN) for Biological and Biotechnological Substances
- Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
- Strategies and Challenges for the Next Generation of Antibody-Drug
- INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri